Commentary

Top Commentary Stories

Voluntary Benefits

The GLP-1 dilemma: Balancing obesity care with a 12% spike in drug spend

By Kryijztoff Novotnaj and Nelly Rose

Recommended Just For You

Commentary Stories

January 22, 2026

January 21, 2026

January 20, 2026

January 19, 2026

January 15, 2026

January 14, 2026

January 13, 2026